Skip to content
中文产业新闻精选评分76Chinese source

Moderna 个性化 mRNA 肿瘤疫苗 INTerpath-001 三期随机对照试验取得阳性结果

大涨 177%!Moderna 个性化 mRNA 肿瘤疫苗 3 期临床成功

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.